What are the sensitivity and specificity of the Typhi IgM (Typhidot) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sensitivity and Specificity of Typhi IgM Test (Typhidot)

The Typhidot IgM test has variable and suboptimal performance characteristics, with sensitivity ranging from 56-97% and specificity from 31-97% across studies, and should not be used as the sole basis for diagnosing typhoid fever 1.

Guideline Recommendations

The UK guidelines for fever in returned travelers explicitly state that rapid serological tests detecting IgM against specific antigens (including Typhidot, Typhidot-M, and Tubex) "have been developed, but so far have shown mixed results" and are not recommended as standalone diagnostic tools 1. These guidelines emphasize that blood culture remains the gold standard, with sensitivity of 40-80% within the first week of symptoms.

Research Evidence on Test Performance

Most Recent High-Quality Study

The 2021 Cameroon study provides the most recent comprehensive evaluation 2:

  • Sensitivity: 80.56%
  • Specificity: 94.03%
  • Positive Predictive Value: 66.6%
  • Negative Predictive Value: 97.03%

This study used a composite reference standard (fever plus positive culture for S. typhi/paratyphi) and found that while Typhidot-IgM performed better than the Widal test, it was still not ideal for clinical decision-making.

Supporting Evidence

A 2015 Indian study comparing two rapid IgM tests found 3:

  • Typhidot-IgM: 97.29% sensitivity, 97.40% specificity
  • However, this study used blood culture as the sole reference standard, which itself has limited sensitivity

A 2013 systematic review and meta-analysis specifically concluded that the observed performance of Typhidot "does not support the use of either rapid diagnostic test exclusively as the basis for diagnosis and treatment" 4. Across studies, Typhidot sensitivity ranged from 56-84% and specificity from 31-97%.

Clinical Implications

Key Pitfalls to Avoid:

  • Never rely on Typhidot-IgM alone to rule in or rule out typhoid fever
  • The wide variation in performance across different populations and settings makes it unreliable
  • False positives can lead to unnecessary antibiotic use and missed alternative diagnoses
  • False negatives can delay appropriate treatment in true typhoid cases

Recommended Diagnostic Approach:

  1. Blood culture remains the primary diagnostic test - collect before antibiotics if possible
  2. Use Typhidot-IgM only as an adjunct when:
    • Clinical suspicion is high (fever, appropriate travel history, compatible symptoms)
    • Blood culture is negative or unavailable
    • Combined with clinical judgment
  3. Empirical treatment should be based on clinical suspicion and epidemiology, not test results alone, particularly in unstable patients 1

Treatment Considerations:

When typhoid is strongly suspected clinically, initiate empirical treatment with IV ceftriaxone (especially for patients from Asia where fluoroquinolone resistance exceeds 70%), rather than waiting for serological confirmation 1.

The Typhidot-IgM test may detect up to 72% of additional cases among blood culture-negative patients 3, but this must be interpreted cautiously given the potential for false positives in endemic areas where background seropositivity is common.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.